Need a specific person's email?
Browse VectivBio AG's employee directory (about 61 employees) and reveal verified emails free.
VectivBio AG's most common email format is First.Last@vectivbio.com (ex. John.Doe@vectivbio.com), used for 97% of vectivbio.com addresses. VectivBio AG uses 2 email patterns.
| Format | Example | Share of vectivbio.com |
|---|---|---|
| First.Last@vectivbio.comMost common | John.Doe@vectivbio.com | |
| First.Middle@vectivbio.com | John.Michael@vectivbio.com |
Browse VectivBio AG's employee directory (about 61 employees) and reveal verified emails free.
Biotechnology ResearchBasel-Stadt, Switzerland51-200 Employees
VectivBio AG is a Basel, Switzerland-based clinical-stage biotechnology company focused on rare diseases and targeting conditions with clearly defined biology through transformative therapeutics. It originated in 2019 as a spinout from Therachon, a company whose achondroplasia program was acquired by Pfizer. The firm’s lead program addresses Short Bowel Syndrome, and its collaboration strategy includes an exclusive license with Asahi Kasei Pharma to develop apraglutide for multiple indications, including SBS with intestinal failure and steroid-refractory acute graft-versus-host disease, with potential future Japan indications. In 2023, VectivBio announced a merger with Ironwood Pharmaceuticals. The company employs 51 to 200 people and maintains a website at vectivbio.com.
Most common format
First.Last@vectivbio.com
Example: John.Doe@vectivbio.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.